Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2011-01-25
2011-01-25
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S252130, C540S484000, C544S373000
Reexamination Certificate
active
07875605
ABSTRACT:
N-arylsulfonyl-3-substituted indole compounds, derivatives, analogs, tautomeric forms, stereoisomers, geometric forms, N-oxides, polymorphs and pharmaceutically acceptable salts.
REFERENCES:
patent: 4839377 (1989-06-01), Bays et al.
patent: 4855314 (1989-08-01), Oxford et al.
patent: 5298491 (1994-03-01), Chauveau et al.
patent: 6255306 (2001-07-01), Macor
patent: 1345724 (2002-04-01), None
patent: 303506 (1989-02-01), None
patent: 313397 (1989-04-01), None
patent: 354777 (1990-02-01), None
patent: 438230 (1991-07-01), None
patent: 457701 (1991-11-01), None
patent: 497512 (1992-08-01), None
patent: 1305458 (1973-01-01), None
patent: 2035310 (1980-06-01), None
patent: 05043544 (1993-02-01), None
patent: 2000344744 (2000-12-01), None
patent: 9118897 (1991-12-01), None
patent: WO-9213856 (1992-08-01), None
patent: 9300086 (1993-01-01), None
patent: 9323396 (1993-11-01), None
patent: 9406769 (1994-03-01), None
patent: WO-9603400 (1996-02-01), None
patent: WO-0247687 (2002-06-01), None
patent: WO-02058702 (2002-08-01), None
Sudha R. Vippagunta et al., Crystalline Solids; Advanced Drug Delivery Reviews; vol. 48, issue 1, May 16, 2001, pp. 3-26.
Le Borgne, M. et al, “New selective nonsteroidal . . . ”, Bioorganic & Medicinal Chemistry Letters, 1999, 333-336, vol. 9, No. 3, Elsevier Science Ltd, GB.
Nagarathnam, D., et al, “A Facile Synthesis of 3-Substituted Indoles”, J. Heterocyclic Chem., 1992, 953-958, vol. 29, Univ. of Illinois at Chicago, Chicago, IL.
Marchand, P. et al, “3(azotylmethy1)1H-indoles as . . . ”, Pharmacy and Pharmacology Commun, 1998, 211-218, vol. 4, No. 4, CAPLUS Online, Royal Pharm. Society of Great Britain, GB.
Ketcha, D.M. et al, “A Convenient Synthesis of 3-Acylindoles . . . ”, The Journal of Organic Chemistry, 1985, 5451-5457, vol. 50, No. 26, American Chemical Society, NH.
Seebach, D. et al, “Design and Synthesis of gamma-Dipeptide Derivatives . . . ”, Angew. Chem. Int., 2003, 776-778, vol. 42, No. 7, Wiley-VCH Verlag GmbH 7 Co. KGaA, Weinheim.
Zhang, P. et al, “Regiospecific Bromination of 3-Methylindoles . . . ”, Tetrahedron Letters, 1995, 3103-3106, vol. 36, No. 18, Elsevier Science Ltd, GB.
Nagarathnam, D., et al, Synth. Commun., 1993, 2011-2017, vol. 23, No. 14, Beilstein Online Registry No. 6339193, Frankfurt, DE.
Buttery, Cheryl D., et al., Chem. Soc. Perkin Trans., 1993, 1425-1432, vol. 13, Beilstein Online Registry No. 6149229, Frankfurt, DE.
Sato, M., Tetrahedron Lett., 1990, 4697-4698, vol. 31, No. 33, Beilstein Online Registry No. 4193743, Frankfurt, DE.
Boggs, Jason, “Preparation of an electrophilic . . . ”, Journal of the Arkansas Academy of Science, 2000, 33-37, vol. 54, CAPLUS Online, AR, USA.
Benedetti, F., J. Chem. Soc. Chem. Commun., 1996, 1417-1418, vol. 12, Beilstein Online Registry No. 7538920, Frankfurt, DE.
Mouaddib, A., Synth. Commun,, 2000, 549-556, vol. 4, Beilstein Online Registry No. 8491943, Frankfurt, DE.
Babu, S.D., Can. J. Chem., 1989, 1071-1076, vol. 67, Beilstein Online Registry No. 4488731, Frankfurt, DE.
Malleron, J-L. et al, “New Indole Derivatives as Potent and Selective . . . ”, Journal of Medicinal Chemistry, 1993, 1194-1202, vol. 36, vol. 36, No. 9, Cedex, France.
Mutulis, Felikss et al, “Reductive Amination Products Containing . . . ”, Bioorganic & Medicinal Chemistry Letters, 2002, 1035-1038, vol. 12, No. 7, Elsevier Science Ltd., GB.
Russel M G N et al, “N-Arylsulfonylindole derivatives as . . . ”, Journal of Medicinal Chemistry, 2001, 3881-3895, vol. 44, No. 23, American Chemical Society, Washington, US.
Degraw, J.I. et al., Journal of Medicinal Chemistry, 1966, 140-142, 9, Beilstein Online Registry No. 1592954, Frankfurt, DE.
Love, B.E., Syn. Lett., 1998, 1123-1125, Beilstein Online Registry No. 885083, Frankfurt, DE.
International Search Report issued in counterpart PCT Appln No. PCT/IN2003/000209.
Written Opinion issued in counterpart PCT Appl No. PCT/IN2003/000209.
International Preliminary Report on Patentability issued in counterpart PCT Appln No. PCT/IN2003/000209.
Shen, Y., et al., “Molecular Cloning and Expression of a 5-Hydroxytryptamine7 Serotonin Receptor Subtype”, J. Biol. Chem., (1993) pp. 18200-18204, vol. 268.
Saxena, P.R., et al., “Cardiovascular Effects of Serotonin Agonists and Antagonists”, Journal of Cardiovascular Pharmacology, (1990), 15 (Supp 7): S17-S34, Raven Press, Ltd.
Glennon, R., et al., “Serotonin Receptors: Clinical Implications”, Neuroscience and Behavioral Reviews, (1990), pp. 35-47, vol. 14, Pergamon Press.
Hoyer, D., et al., “VII. International Union of Pharmacology Classification of Receptors for 5-Hydroxytrypatamine (Serotonin)”, Pharmacol Rev., (1994), pp. 157-203, vol. 46, The American Society for Pharmacology and Experimental Therapeutics.
Monsma,F., et al., “Cloning and Expression of Novel Serotonin Receptor with High Affinity for Tricyclic Psychotropic Drugs”, Mol. Pharmacol., (1993), pp. 320-327, vol. 43, The American Society for Pharmacology and Experimental Therapeutics.
Ruat, M., et al., “A Novel Rat Serotonin (5-HT6) Receptor: Molecular Cloning, Localization and Stimulation of camp accumulation”, Biochem. Biophys. Res. Com., (1993), pp. 268-276, vol. 193, Academic Press, Inc.
Roth, B., et al., “Binding of Typical and Atypical Antipsychotic Agents to 5-Hydroxytryptamine-6 and 5-Hydroxytryptamine-7 Receptors”, J. Pharm. Exp. Therapeut., (1994), pp. 1403-1410, vol. 268, The American Society for Pharmacology and Experimental Therapeutics.
Sleight, A., et al., “The 5-Hydroxytryptamine6 Receptor: Localisation and Function”, Exp. Opin. Ther. Patents, (1998), pp. 1217-1224, vol. 8, Ashley Publications Ltd.
Bourson, A., et al., “Involvement of 5-HT6 Receptors in Nigro-striatal Function in Rodents”, Brit. J. Pharmacol., (1998), pp. 1562-1566, vol. 125, Stockton Press.
Boess, F., et al., “The 5-Hydroxytryptamine6 Receptor-Selective Radioligand [3H]Ro 63-0563 Labels 5-Hydroxytryptamine Receptor Binding Sites in Rat and Porcine Striatum”, Mol. Pharmacol., (1998), pp. 577-583, vol. 54. The American Society for Pharmacology and Experimental Therapeutics.
Sleight, A., et al., “Characterization of Ro 04-6790 and Ro 63-0563: Potent and Selective Antagonists at Human and Rat 5-HT6 Receptors”, Brit. J. Pharmacol., (1998), pp. 556-562, vol. 124, Stockton Press.
Yoshioka, M., et al., “Central Distribution and Function of 5-HT6 Receptor Subtype in the Rat Brain”, Life Sciences, (1998), pp. 1473-1477, vol. 62, Elsevier Science Inc.
Schoeffter, P., et al., “SDZ 216-525, a Selective and Potent 5-HT1A Receptor Antagonist”, European Journal of Pharmacology, 1993, pp. 251-257, vol. 244, Elsevier Science.
Hoyer, D., et al., “Molecular Pharmacology of 5-HT1 and 5-HT2 Recognition Sites in Rat and Pig Brain Membranes . . . ”, Eur. Jrnl. Pharmacol., (1985), pp. 13-23, vol. 118, Elsevier.
Grossman, C.J., et al., “Development of a Radioligand Binding Assay for 5HT4 Receptors in Guinea Pig and Rat Brain”, Brit., Jrnl. Pharmacol., (1993), pp. 618-624, vol. 109, Macmillan Press.
Rees, S., et al, “Cloning and Characterisation of the Human 5-HT5A Serotonin Receptor”, FEBS Letters, (1994), pp. 242-246, vol. 355, Federation of European Biochemical Societies.
Lummis, S.C.R., et al., “Characterization of 5HT3 Receptors in Intact N1E-115 Neuroblastoma Cells”, Eur. Jrnl. Pharmacol., (1990), pp. 223-227, vol. 189, Elsevier.
Hoyer, D. and Neijt, H.C., “Identification of Serotonin 5-HT3 Recognition Sites in Membranes of N1E-115 Neuroblastoma Cells by Radioligand Binding”, Mol. Pharmacol., (1988), pp. 303-309, vol. 33, The American Society for Pharmacology and Experimental Therapeutics.
Schoeffter, P., and Hoyer, D., “How Selective is GR 43175? Interactions with Functional 5-HT1A, 5-HT1B, 5-HT1C and 5-HT1D Recept
Jasti Venkateswarlu
Kambhampati Rama Sastri
Ramakrishna Venkata Satya Nirogi
Rao Venkata Satya Veerabhadra Vadlamudi
Shirsath Vikas Shreekrishna
IpHorgan Ltd.
Sackey Ebenezer
Suven Life Sciences Limited
Wilson James O
LandOfFree
N-arylsulfonyl-3-substituted indoles having serotonin... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-arylsulfonyl-3-substituted indoles having serotonin..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-arylsulfonyl-3-substituted indoles having serotonin... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2716170